Medication beliefs and depression in Black individuals with diabetes and mild cognitive impairment
Authors:
Open Access
- 8 August 2024
- journal article
- research article
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 72 (12) , 3920-3922
Abstract
No abstract availableFunding Information
- National Institute on Aging (R01AG065467)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK102609‐01)
This publication has 10 references indexed in Scilit:
- A randomized controlled trial to test the efficacy of a diabetes behavioral intervention to prevent memory decline in older blacks/African Americans with diabetes and mild cognitive impairmentContemporary Clinical Trials, 2022
- Medication Beliefs and Depression in African Americans With DiabetesThe American Journal of Geriatric Psychiatry, 2021
- Improving Glycemic Control in African Americans With Diabetes and Mild Cognitive ImpairmentJournal of the American Geriatrics Society, 2020
- Effect of Depression and Diabetes Mellitus on the Risk for DementiaJAMA Psychiatry, 2015
- Depressive Symptoms and Diabetes Control in African AmericansJournal of Immigrant and Minority Health, 2008
- The mediating role of health beliefs in the relationship between depressive symptoms and medication adherence in persons with diabetesResearch in Social and Administrative Pharmacy, 2005
- The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive ImpairmentJournal of the American Geriatrics Society, 2005
- The PHQ-9Journal of General Internal Medicine, 2001
- The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medicationPsychology & Health, 1999
- “Mini-mental state”Journal of Psychiatric Research, 1975